Preprint Review Version 1 This version is not peer-reviewed

Nutraceutical Strategies for Aging: Looking Towards Parkinson’s Disease and Frailty

Version 1 : Received: 25 September 2024 / Approved: 26 September 2024 / Online: 26 September 2024 (07:17:30 CEST)

How to cite: Montanari, M.; Mercuri, N. B.; Martella, G. Nutraceutical Strategies for Aging: Looking Towards Parkinson’s Disease and Frailty. Preprints 2024, 2024092082. https://doi.org/10.20944/preprints202409.2082.v1 Montanari, M.; Mercuri, N. B.; Martella, G. Nutraceutical Strategies for Aging: Looking Towards Parkinson’s Disease and Frailty. Preprints 2024, 2024092082. https://doi.org/10.20944/preprints202409.2082.v1

Abstract

Aging is a complex and inevitable biological process characterized by a gradual decline in physiological function, including increased oxidative stress, chronic inflammation, and mitochondrial dysfunction. While aging is a natural part of life, it is often accompanied by various disorders collectively known as age-related diseases (ARDs) or aging disorders. These include neurodegenerative diseases like Parkinson’s (PD), cardiovascular diseases, diabetes, osteoporosis, and frailty, among others. As the global population ages, the prevalence of ARDs such as PD and frailty is rising, necessitating innovative approaches to enhance healthy aging. Nutraceuticals are natural bioactive compounds in foods that offer health benefits beyond essential nutrition, which is pivotal in preventing and managing aging-related disorders. Nutraceuticals, with their antioxidant, anti-inflammatory, and neuroprotective properties, offer promising strategies to counteract these processes and promote healthy aging. This review highlights the potential of nutraceuticals as valuable adjuncts in managing PD and frailty, two conditions intricately linked to ARD. By examining the differential impacts of these bioactive compounds on the underlying mechanisms of each condition, this study underscores the promise of nutraceuticals in promoting healthy aging. The review aims to inform future research and clinical strategies by advocating for developing novel bioactive compounds, using advanced delivery technologies, and integrating personalized approaches based on genetic and epigenetic profiles. These efforts will pave the way for more precise, effective, and individualized interventions, ultimately extending health span and preventing ARD.

Keywords

Aging; Precision Medicine; Parkinson’s Disease; Frailty; Nutraceuticals; Bioactive Compound; Physiology and Anatomy; Anti-Oxidant; Inflammation

Subject

Biology and Life Sciences, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.